Bulletin
Investor Alert

New York Markets Close in:

Vir Biotechnology Inc.

NAS: VIR

GO
/marketstate/country/us

Market open

VIR
/zigman2/quotes/214486077/composite

$

48.86

Change

+1.64 +3.47%

Volume

Volume 17,572

Apr 20, 2021, 9:45 a.m.

Real time quotes

/zigman2/quotes/214486077/composite

Previous close

$ 47.22

$ 48.86

Change

+1.64 +3.47%

Day low

Day high

$47.26

$48.89

Open
Open: 47.53

52 week low

52 week high

$25.31

$141.01

Open

Market cap

$5.76B

Average volume

1.31M

P/E ratio

N/A

Rev. per Employee

$233,541

EPS

-2.49

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/vir

MarketWatch News on VIR

  1. Lilly, Vir and Glaxo say combined monoclonal antibodies found 70% reduction in high viral load at day 7

    8:33 a.m. March 29, 2021

    - Ciara Linnane

  2. Eli Lilly, Vir and Glaxo announce positive data in Phase 2 trial of COVID antibody treatment

    8:33 a.m. March 29, 2021

    - Ciara Linnane

  3. GSK and Vir Submit Covid-19 Drug for FDA Authorization

    9:49 a.m. March 26, 2021

    - Josh Nathan-Kazis

  4. Glaxo and Vir say data from Phase 3 trial of antibody treatment shows 85% reduction in hospitalization or death

    8:33 a.m. March 26, 2021

    - Ciara Linnane

  5. GlaxoSmithKline and Vir Biotech have submitted EUA request to FDA for COVID antibody treatment

    8:32 a.m. March 26, 2021

    - Ciara Linnane

  6. You Can Buy a Tesla With Bitcoin Now

    8:28 a.m. March 24, 2021

  7. Regeneron Stock Climbs on Positive Covid-19 Antibody Data

    9:17 a.m. March 23, 2021

    - Josh Nathan-Kazis

  8. Regeneron Stock Climbs on Positive Covid-19 Antibody Data

    9:17 a.m. March 23, 2021

    - Josh Nathan-Kazis

  9. WHO declared a pandemic one year ago today

    6:59 a.m. March 12, 2021

    - Ciara Linnane

  10. Vir's Covid-19 Antibody Works Well, Sending Shares Flying

    8:38 a.m. March 11, 2021

    - Josh Nathan-Kazis

  11. Loading more headlines...
/news/nonmarketwatch/company/us/vir

Other News on VIR

  1. Could Vir Biotechnology Be a Millionaire Maker Stock?

    6:00 a.m. April 17, 2021

    - Motley Fool

  2. EMA begins review of GSK/Vir early COVID-19 treatment VIR-7831

    10:53 a.m. April 15, 2021

    - Seeking Alpha

  3. Vir Biotechnology highlights new sars-cov-2 research

    9:13 a.m. April 8, 2021

    - Seeking Alpha

  4. Lilly/Vir's Cocktail COVID-19 Therapy Meets Study Endpoint

    9:01 a.m. March 30, 2021

    - Zacks.com

  5. Pair of Covid-19 Drugs Show Promise

    5:36 p.m. March 29, 2021

    - Joseph Walker

  6. Pair of Covid-19 Drugs Show Promise

    12:20 p.m. March 29, 2021

    - Joseph Walker

  7. Loading more headlines...
/news/pressrelease/company/us/vir

Press Releases on VIR

  1. The Need for Comprehensive Diagnostics Remains as Cases Spike Once More

    45 min ago

    - PR Newswire - PRF

  2. Vir Pushes for FDA Nod

    11:15 a.m. March 26, 2021

    - Baystreet.ca

  3. Effective Diagnostics Help to Tame the Spread of the Pandemic

    9:00 a.m. March 24, 2021

    - PR Newswire - PRF

  4. Are These The Top Health Care Stocks To Buy In Right Now?

    7:01 p.m. March 11, 2021

    - StockMarket.com

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.